Found 8 matching trials
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
PHASE3This is a phase 3 randomized, double -masked study comparing the efficacy o...
Location
California Retina Consultants
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
PHASE3This is a phase 3 randomized, double -masked study comparing the efficacy o...
Status
Active Not Recruiting
Location
Associated Retina Consultans
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
PHASE2A prospective, randomized, single-masked study evaluating the ocular effica...
Location
EyePoint Investigative Site
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
PHASE2A prospective, randomized, double-masked study that evaluated the ocular ef...
Location
EyePoint Investigative Site
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
PHASE3This is a phase 3 randomized, double -masked study comparing the efficacy o...
Status
Active Not Recruiting
Location
Retinal Research Institute, LLC
Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)
PHASE2This is a phase 2 randomized, double -masked study comparing the efficacy o...
Location
EyePoint Investigative Site
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
PHASE3This is a phase 3 randomized, double -masked study comparing the efficacy o...
Location
Associated Retina Consultans
First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)
PHASE1Phase 1 open-label study to assess the bioactivity, ocular and systemic saf...
Location
EyePoint Investigational Site